Department of Biomedicine and Prevention, University of Rome Tor Vergata;
Luca Filippi is an Associate Professor of Nuclear Medicine with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata, Rome, Italy. His research interests cover molecular and metabolic imaging PET/SPECT and targeted therapy, with specific focus, in recent years on multi-tracer imaging (18F-choline/18F-FACBC/PMSA-ligands) for the study of prostate carcinoma, applications of PET/CT with 18F-FDG in skin tumors undergoing treatment with immune checkpoint inhibitors and applications of artificial intelligence and radiomics. Prof. Filippi is head of the AI/radiomics Study Group of the Italian Association of Nuclear Medicine, Molecular Imaging and Therapy (AIMN) and editor-in-chief of Expert Review of Medical Devices. He promotes academic and corporate teaching initiatives aimed at engaging youth in hybrid imaging, theranostics and radiomics. His scholarly contributions include five book chapters and over 230 Scopus-indexed papers.

Faculty of Medicine, Universidade do Porto;
Inês Domingues is an Assistant Professor at the Faculty of Medicine of the University of Porto and a researcher at CI-IPOP and RISE-Health. Her work lies at the intersection of Artificial Intelligence, Data Science, Medical Imaging, and Health Decision Support Systems. Her research focuses on AI-driven biomedical and oncological image analysis, with applications in cancer diagnosis and prognosis, radiomics, medical imaging, and healthcare data science. She has authored more than 60 scientific publications, participated in several funded research projects, and served on more than 70 scientific committees. Alongside her research activities, she is strongly committed to teaching, supervision, and pedagogical innovation. She also contributes actively to the scientific community through editorial roles, peer review, conference organization, and involvement in professional associations, including APRP and IAPR.

Department of Neurosurgery, Río Hortega University Hospital, Specialized Group in Biomedical Imaging and Computational Analysis (GEIBAC); Instituto de Investigación Biosanitaria de Valladolid (IBioVALL;
Santiago Cepeda, MD, PhD, is a consultant neurosurgeon at Hospital Universitario Río Hortega in Valladolid, Spain, working at the intersection of neurosurgical oncology and computational medical imaging. He completed his residency in neurosurgery at Hospital Universitario 12 de Octubre in Madrid, earned his doctorate cum laude from Universidad Complutense de Madrid, and holds a postgraduate diploma in translational oncology from the same university. He leads GEIBAC, a research group dedicated to biomedical imaging and computational analysis, where he develops and clinically validates artificial intelligence systems for neuro-oncology and neurovascular disease, writing and deploying the code behind them himself. Several of these tools are openly available and integrated into routine clinical workflows. Dr. Cepeda is the principal investigator of investigator-initiated clinical trials in neuro-oncology and intraoperative imaging, funded by the Instituto de Salud Carlos III and regional agencies, and coordinates multicenter collaborations across Europe and North America. His current work focuses on artificial intelligence applied to intraoperative ultrasound, spatial mapping of tumor infiltration, and the biological validation of AI-derived imaging biomarkers.